Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia

The primary objective of the study is the evaluation of sustained response rate after discontinuation of treatment with TPO-RAs, Eltrombopag and Romiplostim, in persistent or chronic pITP patients who failed one or more therapy lines, splenectomy included. Increasing evidence exists in the literature on the persistent response after TPO-RAs discontinuation.

Italy

https://clinicaltrials.gov/ct2/show/NCT02298075?recrs=a&cond=ITP&draw=1&rank=23

Recruiting

back to top

BBB Cleveland logo GuideStar Seal NORD Member Badge 2018THSNA logo